Why the study?
Does solitary beta-adrenergic blocker therapy reduce arrhythmia and symptoms in patients with life-threatening ventricular tachyarrhythmia without structural heart disease associated with psychological stress?
Does solitary beta-adrenergic blocker therapy reduce arrhythmia and symptoms in patients with life-threatening ventricular tachyarrhythmia without structural heart disease associated with psychological stress?
Beta-blocker therapy may be effective in reducing arrhythmias and symptoms in patients with life-threatening ventricular tachyarrhythmia without structural heart disease triggered by psychological stress.
Answers are grounded in this paper and cite their sources.
May support beta-blocker trial in stress-triggered VT without structural disease; hypothesis-generating and requires prospective confirmation.
Psychological stress has been reported to be a risk factor for sudden cardiac death in individuals both with and without underlying structural heart disease. From a group of 80 patients presenting with life-threatening ventricular tachyarrhythmia, six were identified without underlying structural heart disease. Five of these six patients experienced marked psychological stress. Each of these five patients underwent arrhythmia evaluation, demonstrating recurrent rapid monomorphic ventricular tachycardia related to changes in tone of the sympathetic nervous system. Subsequently, solitary beta-adrenergic blocker therapy was given to each patient. During therapy, four of the five patients had a marked reduction of both arrhythmia and symptoms during a follow-up ranging from 29 to 49 (mean, 38) months.
No takes yet. Share an insight, caveat, or question.
Michael A. Brodsky (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: